Ovarian Reserve Testing is now available directly to consumers. This is an empowering development but the interpretation of results should be discussed with a medical professional.
In theory, this would allow for more precise planning about when to have a baby or to make a more refined estimate about IVF success rates. These tests are not genetic tests discussed in other blogs.
One such company is:
https://www.letsgetchecked.com/home-female-hormone-ovarian-reserve-test/
This test is only looking at the Anti-Mullerian Hormone to estimate where a woman is within the Ovarian Lifecycle. AMH is a predictor of the onset of menopause.
This is only one marker that reproductive endocrinologists use to assist them in producing more eggs within a single cycle and estimating success.
Lapcorp also offers a panel that doesn’t require a doctor’s prescription.
Ovarian Reserve | Women’s Reproductive Health (labcorp.com)
The medical community is not in consensus about the validity of such tests to denote fertility as noted in this article.
https://jamanetwork.com/journals/jama/article-abstract/2656811
Key Points
Question Is diminished ovarian reserve, as measured by low antimüllerian hormone (AMH), associated with infertility among women of late reproductive age?
Findings In this time-to-pregnancy cohort study of women aged 30 to 44 years without a history of infertility, women with a low AMH value had an 84% predicted cumulative probability of conception by 12 cycles of pregnancy attempt compared with 75% in women with a normal AMH value, a nonsignificant difference.
Meaning Among women attempting to conceive naturally, diminished ovarian reserve was not associated with infertility; women should be cautioned against using AMH levels to assess their current fertility.